1.
Rudzinski JK,
Kawakami J.,
(2014).
Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary,
Alberta,
Canada: A retrospective population-based analysis. Can Urol Assoc J 2014;8(5-6): e301-5. http://dx.doi.org/10.5489/cuaj.1751.
2.
Chan ES,
Lo KL,
Ng CF,
Hou SM,
Yip SK.
(2012).
A randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy.
Chin Med J (Engl),
125:2432-5.
3.
Yip SKh,
Sim HG.
(2010) Robotic radical prostatectomy in East Asia: development,
surgical results,
and challenges. Curr Opin Urol,
20:80-5.
4.
Rietbergen JB,
Kruger AE,
Kranse R,
Schroder FH.
(1997).
Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.
Urology; 49:875-80.
5.
Webb NR,
Woo HH.
(2002).
Antibiotic prophylaxis for prostate biopsy. BJU Int.;89:824-8.
6.
Ghani KR,
Dundas D,
Patel U.(2004).
Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-,
eight- and 12-core biopsy protocol.
BJU Int.;94:1014-20.
7.
Hambardzumyan A.
M.
(2003).
Transrectal Ultrasound prostate biopsy.
3rdCaucasian Congress of Oncologist,
Yerevan,
22-24 September,
2004.p.
45.